Skip to content

Clinical trials

Terminated Phase 2 trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Terminated Country / region: Taiwan Clear all

188 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20072
20085
20093
201010
20118
201214
20138
20148
20159
20164
201711
201815
201924
202011
202119
202216
202312
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated188

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals28
AstraZeneca10
Pfizer9
Amgen8
Boehringer Ingelheim6
Hoffmann-La Roche5
Janssen Research & Development, LLC5
AbbVie4
Bristol-Myers Squibb4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung18
Neoplasms11
Breast Neoplasms10
Carcinoma, Hepatocellular9
Squamous Cell Carcinoma of Head and Neck8
Arthritis, Rheumatoid6
Head and Neck Neoplasms6
Neoplasm Metastasis6
Idiopathic Pulmonary Fibrosis5
Lupus Erythematosus, Systemic5

Trials

Showing 1 to 25 of 188. Each trial links to its page on Pharma Observatory.

88 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.